Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),

Updated on: December 25,2023 15

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),

Updated on:December 25,2023 15

New antibody shows strong potential as treatment against pancreatic cancer

New antibody shows strong potential as treatment against pancreatic cancerbyTranslational Genomics Research InstituteSIWA318H treatment depletes p16INK4apositive cells and reduces αSMA exp

Updated on: October 30,2023 7

New antibody shows strong potential as treatment against pancreatic cancer

New antibody shows strong potential as treatment against pancreatic cancerbyTranslational Genomics Research InstituteSIWA318H treatment depletes p16INK4apositive cells and reduces αSMA exp

Updated on:October 30,2023 7

Hormonal breast cancer treatment reduces long-term risk of recurrence

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of

Updated on: December 18,2023 14

Hormonal breast cancer treatment reduces long-term risk of recurrence

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainTo investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of

Updated on:December 18,2023 14

Step forward in leukemia treatment

by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen

Updated on: December 22,2023 16

Step forward in leukemia treatment

by South Australian Health and Medical Research InstituteCredit: AI-generated imageAn international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-gen

Updated on:December 22,2023 16

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Updated on: December 22,2023 9

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Updated on:December 22,2023 9

Study finds African Americans with cancer at higher risk for blood clots

byBoston University School of MedicineCredit: CC0 Public DomainAfrican-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

Updated on: December 22,2023 25

Study finds African Americans with cancer at higher risk for blood clots

byBoston University School of MedicineCredit: CC0 Public DomainAfrican-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

Updated on:December 22,2023 25

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according

Updated on: December 17,2023 10

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according

Updated on:December 17,2023 10

UGN-101 reviewed in real-world upper tract urothelial cancer setting

by Elana GotkineFor patients with upper tract urothelial cancers (UTUCs), the novel therapeutic UGN-101 seems to be effective, with an acceptable safety profile, according to research published online

Updated on: December 17,2023 6

UGN-101 reviewed in real-world upper tract urothelial cancer setting

by Elana GotkineFor patients with upper tract urothelial cancers (UTUCs), the novel therapeutic UGN-101 seems to be effective, with an acceptable safety profile, according to research published online

Updated on:December 17,2023 6

Cell therapy could improve bone marrow transplant safety

by Tiare Dunlap,University of California, Los AngelesGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104859UCLA researchers report a step forward in the developme

Updated on: January 10,2024 9

Cell therapy could improve bone marrow transplant safety

by Tiare Dunlap,University of California, Los AngelesGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104859UCLA researchers report a step forward in the developme

Updated on:January 10,2024 9

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i

Updated on: November 19,2023 18

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i

Updated on:November 19,2023 18

How employers can help cancer survivors return to work

by Stephen Bevan,The ConversationCredit: AI-generated imageWhen I lost a relative to cancer in the late 1970s, people usually viewed a cancer diagnosis with horror. At the time, many treatments

Updated on: December 20,2023 17

How employers can help cancer survivors return to work

by Stephen Bevan,The ConversationCredit: AI-generated imageWhen I lost a relative to cancer in the late 1970s, people usually viewed a cancer diagnosis with horror. At the time, many treatments

Updated on:December 20,2023 17

Survival is a mixed matter for deadliest of pancreatic cancers

byUniversity of California - San DiegoPancreatic cancer cells (nuclei in blue) are shown growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic ductal adenoc

Updated on: December 21,2023 6

Survival is a mixed matter for deadliest of pancreatic cancers

byUniversity of California - San DiegoPancreatic cancer cells (nuclei in blue) are shown growing as a sphere encased in membranes (red). Credit: National Cancer InstitutePancreatic ductal adenoc

Updated on:December 21,2023 6